In 2019, we achieved reported net sales growth of 9.4% and continued our capital allocation strategy by investing in acquisitions, which reflects our commitment to enhancing our IT capabilities and supporting business needs. Our capital allocation strategy prioritizes acquisitions, dividends, and share repurchases, indicating a focus on leveraging strategic resources for competitive advantage. We completed acquisitions for total net cash consideration of $802 million, which are expected to enhance our operational efficiency and integrate advanced technologies into our business processes. The integration of acquired companies, such as Wright Medical Group, into our existing operations is aimed at enhancing our trauma and extremities business, thereby transforming our capabilities in the medical technology sector. Our research, development, and engineering expenses, which increased to 6.5% of net sales, underscore our investment in technology resources and innovation, essential for maintaining market agility and responsiveness to consumer demands. The increase in gross profit as a percentage of net sales reflects our ability to manage operational costs effectively while investing in new technologies that align with our business strategy. Our focus on operational flexibility and capability enhancement is evident in our strategic resource allocation, which aims to optimize our internal processes and improve overall firm performance. We also emphasize the importance of information management capability, ensuring that data and information are provided to users with appropriate levels of accuracy, timeliness, and reliability, which is critical for informed decision-making and maintaining competitive positioning. The operational cash flow generated from our activities supports our ongoing investments in technology infrastructure and digital transformation efforts, which are vital for sustaining long-term growth and enhancing our organizational capabilities. Our ability to mobilize and deploy IT-based resources in combination with other organizational resources is a key factor in achieving our strategic objectives and enhancing our market-based performance. The challenges associated with integrating new technologies and managing regulatory compliance are acknowledged, and we continue to adapt our governance practices to ensure alignment with evolving market dynamics. Our commitment to leveraging big data and analytics further supports our operational efficiency and enhances our capacity for innovation. The strategic decisions made regarding acquisitions and investments in IT capabilities reflect our focus on long-term value creation and the importance of aligning our business strategies with technological advancements. Overall, our emphasis on enhancing IT capabilities and integrating innovative solutions into our business processes positions us to respond effectively to market changes and consumer expectations, thereby driving sustainable growth and improving organizational performance.